Multinational characterization of neurological phenotypes in patients hospitalized with COVID-19
Nenhuma Miniatura disponível
Data
2021-12-01
Autores
Le, Trang T.
Gutiérrez-Sacristán, Alba
Son, Jiyeon
Hong, Chuan
South, Andrew M.
Beaulieu-Jones, Brett K.
Loh, Ne Hooi Will
Luo, Yuan
Morris, Michele
Ngiam, Kee Yuan
Título da Revista
ISSN da Revista
Título de Volume
Editor
Resumo
Neurological complications worsen outcomes in COVID-19. To define the prevalence of neurological conditions among hospitalized patients with a positive SARS-CoV-2 reverse transcription polymerase chain reaction test in geographically diverse multinational populations during early pandemic, we used electronic health records (EHR) from 338 participating hospitals across 6 countries and 3 continents (January–September 2020) for a cross-sectional analysis. We assessed the frequency of International Classification of Disease code of neurological conditions by countries, healthcare systems, time before and after admission for COVID-19 and COVID-19 severity. Among 35,177 hospitalized patients with SARS-CoV-2 infection, there was an increase in the proportion with disorders of consciousness (5.8%, 95% confidence interval [CI] 3.7–7.8%, pFDR < 0.001) and unspecified disorders of the brain (8.1%, 5.7–10.5%, pFDR < 0.001) when compared to the pre-admission proportion. During hospitalization, the relative risk of disorders of consciousness (22%, 19–25%), cerebrovascular diseases (24%, 13–35%), nontraumatic intracranial hemorrhage (34%, 20–50%), encephalitis and/or myelitis (37%, 17–60%) and myopathy (72%, 67–77%) were higher for patients with severe COVID-19 when compared to those who never experienced severe COVID-19. Leveraging a multinational network to capture standardized EHR data, we highlighted the increased prevalence of central and peripheral neurological phenotypes in patients hospitalized with COVID-19, particularly among those with severe disease.
Descrição
Palavras-chave
Como citar
Scientific Reports, v. 11, n. 1, 2021.